Internal Control · 2025
In this section9 topics
- Internal Control — Board Opinion1 item
- Adequacy & Appropriateness of the Internal Control System1 item
- Internal Control Deficiencies2 items
- Audit Committee & Auditor Observations2 items
- Opinion on the Head of Internal Audit2 items
- Appointment, Discharge & Transfer of the Head of Internal Audit2 items
- Related Party Transactions1 item
- Counterparties & Transactions3 items
- Policy & Future Trends3 items
Internal Control — Board Opinion
Summary of the Board's Opinion on Internal Control
The Board of Directors is of the opinion that the Company has established an adequate, appropriate, and effective internal control system. The Board of Directors and management have performed their duties and responsibilities in overseeing, establishing, and maintaining the Company's internal control system, including regularly reviewing and evaluating its effectiveness.
The Company's internal control system covers financial control, operational control, oversight of compliance with relevant laws, regulations, and rules, as well as risk management. This system provides reasonable assurance that the Company can achieve its stated objectives and goals, including the accuracy, completeness, and reliability of information systems and financial reports.
Compliance with the company's regulations, policies, work processes, and relevant laws.
The company's assets exist and have been properly controlled, stored, and maintained.
The company's operations are efficient, including the economical use of resources.
The company's objectives and strategies have been achieved and implemented effectively.
At the Audit Committee Meeting No. 4/2025 held on November 11, 2025, the Audit Committee assessed the adequacy of the company's internal control system in accordance with the COSO framework, which consists of 5 components: 1) Control Environment, 2) Risk Assessment, 3) Control Activities, 4) Information and Communication, and 5) Monitoring.
The Audit Committee is of the opinion that the company has an effective internal control system that is adequate for the company's business operations.
No material weaknesses in internal control were identified. The Audit Committee reported this to the Board of Directors for acknowledgement. The Board of Directors concurred with the Audit Committee's opinion that the company has an adequate and appropriate internal control system for its business.
Adequacy & Appropriateness of the Internal Control System
Internal Control Framework Used
| Framework | Detail |
|---|---|
| COSO - Enterprise Risk Management Framework (ERM) | The Company has appointed Dharmniti Internal Audit Co., Ltd., an external audit firm, to audit the Company's internal control system and assess the adequacy of the internal control system. The internal auditors will monitor, control, and maintain the internal control system of the Company's key operations and report to the Audit Committee. The Company has an adequate and appropriate internal control system following the COSO framework, with the following highlights: 1. Internal Control The Company sets clear business objectives and reviews its vision and goals annually. The Board of Directors, executives, and employees perform their duties based on the Company's Code of Business Conduct and Good Corporate Governance Policy. The Board of Directors has independence in performing its duties within the scope of authority as stipulated in the Company's Charter. 2) Risk Assessment The Risk Management Committee has assessed the risk factors that will affect the Company's business operations, both internally and externally, and risk management methods. The report is submitted to the Audit Committee every quarter. 3) Operation Control The Company has established important policies in conducting business to be used as guidelines for operations. The authorization of the Board of Directors and executives at each level is clearly and concisely defined to prevent fraud. The Company has established an internal control system. 4) Information Technology and Data Communication System The Company has appropriate information systems and communication channels both inside and outside the organization. The Board of Directors receives meeting notices and supporting documents in advance of Board meetings. Board meetings are recorded in accurate and complete minutes. 5) Monitoring System The internal control auditors will follow up on the results of the Company's system audits and solutions, reporting directly to the Audit Committee and to the Board of Directors. |
Internal Control Deficiencies
Introduction
The Audit Committee recommended that the internal auditor examine the company's key systems. If any deficiencies are found in any system, the internal control auditor will follow up on the remediation to ensure that the deficiency is resolved.
However, The company did not find any significant deficiencies in 2025.
Number of Deficiencies
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of internal control system deficiencies (cases) | 0 | 0 | 0 |
Audit Committee & Auditor Observations
Audit Committee's Opinion Differs from the Board's
No
Auditor Has Observations on Internal Control
No
Opinion on the Head of Internal Audit
Head of Internal Audit
3160
Audit Committee's Opinion on the Head of Internal Audit
The Audit Committee has appointed Dharmniti Internal Audit Co., Ltd. as the Company's internal auditor, with Ms. Somcharee Kawkomdee serving as the Head of Internal Audit. Dharmniti Internal Audit Co., Ltd. maintains independence in auditing and evaluating the Company's internal control systems. The annual internal audit plan is prepared and reviewed in conjunction with the internal auditor to appropriately cover the Company's important operational processes and systems.
The internal auditor will report the results of the audit and evaluation of internal control systems to the Audit Committee quarterly. The Audit Committee emphasizes having robust and adequate internal control systems to help prevent or mitigate risks that may arise from business operations. Furthermore, the internal control systems are regularly reviewed and monitored for improvements to ensure that they are adequate, appropriate, and comply with relevant internal control standards.
The Audit Committee agrees with the internal auditor that the Company has adequate, appropriate, and effective internal control systems, consistent with the nature and size of the Company's business.
Appointment, Discharge & Transfer of the Head of Internal Audit
Requires Audit Committee Approval
Yes
Description
The Audit Committee will review the performance of the internal audit unit to assess whether its duties are fully performed according to the scope and responsibilities assigned, which supports and promotes good corporate governance processes to enable the organization to efficiently achieve its stated objectives and goals. Furthermore, the internal audit unit is independent of management, possesses sufficient knowledge, capabilities, and understanding of the organization's business risks, and reports its performance directly to the Audit Committee.
In the event that the internal audit unit's performance falls below the set targets, the Audit Committee shall consider approving the appointment, transfer, or termination of the head of the internal audit unit and propose it to the Board of Directors for further consideration and approval of such action.
Related Party Transactions
Has Related Party Transactions
Yes
Counterparties & Transactions
Monetary Unit
1
Counterparties with Potential Conflicts
| Name | Person / Juristic Person | Type of Business | Nature of Relationship | As of Date (YYYY-MM-DD) |
|---|---|---|---|---|
| The Parents Company Limited | Juristic Person | Center of Health Innovation for Longevity | A subsidiary in which the Company holds 80 percent of the shares. | 2025-12-31T00:00 |
| T M Trading Company Limited | Juristic Person | Medical equipment and supply distributor | Subsidiaries in which the Company holds 99.99 percent of shares. | 2025-12-31T00:00 |
| Ms. Prangchai Chanlongbutra | Person | A director of Techno medical Public Company Limited. | 2025-12-31T00:00 | |
| Soonthree Chanlongbutra | Person | A director of Techno Medical Corporation Public Company Limited. | 2025-12-31T00:00 | |
| The Parents Training Center Company Limited | Juristic Person | Nursing School | The company holds shares indirectly through The Parents Co., Ltd. | 2025-12-31T00:00 |
| Dr. Supapong Chanlongbutra | Person | A director of Techno Medical Public Company Limited during the period in which the transaction occurred, and resigned from the position of director on 9 August 2025. | 2025-12-31T00:00 |
Transactions by Counterparty
| Transactions |
|---|
| 240000000.0 · Necessity: To expand the business in the field of health rehabilitation · Description: Techno Medical Public Company Limited invested THB 100 million in a subsidiary on January 16, 2020, and increased its investment by THB 140 million on June 12, 2021, representing an 80% shareholding. (The subsidiary's registered capital is 300 million baht.) · As of yesteryear: 240000000.0 · Nature of transaction: The company invests in subsidiaries. · Audit committee opinion: The Company has transactions with companies or individuals that may have conflicts of interest. These transactions are reasonable, comply with fair trade terms, are treated in the same manner as other unrelated individuals or businesses, and do not involve the transfer of benefits between companies. · As of year before yesteryear: 0.0 · 40912862.35 · Necessity: To support business operations · Description: Techno Medical Public Company Limited has entered into a short-term loan agreement (promissory note). The interest rate is subject to adjustment based on the SCB Bank rate plus 0.02%. The interest payment amounted to THB 912,862.35. · As of yesteryear: 10236536.99 · Nature of transaction: Financial assistance · Audit committee opinion: The Company has transactions with companies or individuals that may have conflicts of interest. These transactions are reasonable, comply with fair trade terms, are treated in the same manner as other unrelated individuals or businesses, and do not involve the transfer of benefits between companies. · 351245.32 · Necessity: For use in caring for the elderly and patients · Description: Techno Medical Public Company Limited sells disposable products that the company distributes. · As of yesteryear: 510022.88 · Nature of transaction: Product Sales · Audit committee opinion: The Company has transactions with companies or individuals that may have conflicts of interest. These transactions are reasonable, comply with fair trade terms, are treated in the same manner as other unrelated individuals or businesses, and do not involve the transfer of benefits between companies. · 7009.35 · Necessity: Employee health benefits · Description: Employees of Technol Medical Public Company Limited are eligible for health benefits. · As of yesteryear: 62032.71 · Nature of transaction: Healthcare Access · Audit committee opinion: The Company has transactions with companies or individuals that may have conflicts of interest. These transactions are reasonable, comply with fair trade terms, are treated in the same manner as other unrelated individuals or businesses, and do not involve the transfer of benefits between companies. · 4000000.0 · Necessity: To expand the business · Description: The Parents Company Limited invested in The Parents Training Center Company Limited on March 22, 2022, with a 99.99% shareholding (registered capital of the subsidiary is 4 million baht). · As of yesteryear: 4000000.0 · Nature of transaction: Investment in a subsidiary · Audit committee opinion: The Company has a list of related parties with which it may have potential conflicts of interest. This list is reasonable, complies with fair trade practices, is treated the same as other unrelated individuals or entities, and does not involve the transfer of benefits between companies. · 1888981.71 · Necessity: As working capital · Description: The Parents Training Center Company Limited entered into a short-term loan agreement (promissory note) with The Parents Company Limited. The interest rate is adjusted according to the LH Bank rate + 0.02% and the promissory note is renewed every 3 months. The total interest amount is THB 88,981.71. · As of yesteryear: 1585433.4 · Nature of transaction: Financial assistance · Audit committee opinion: The Company has transactions with companies or individuals that may have conflicts of interest. These transactions are reasonable, comply with fair trade terms, are treated in the same manner as other unrelated individuals or businesses, and do not involve the transfer of benefits between companies. |
| 5000000.0 · Necessity: To expand the business by focusing on participating in government bidding. · Description: Techno Medical Public Company Limited invested in a subsidiary on July 26, 2022, with a 99.99% shareholding (registered capital of the subsidiary is THB 5 million). · As of yesteryear: 5000000.0 · Nature of transaction: Investment in a subsidiary · Audit committee opinion: The Company has a list of related parties with which it may have potential conflicts of interest. This list is reasonable, complies with fair trade terms and practices consistently applied to other unrelated individuals or entities, and does not involve any transfer of benefits between the Company. · 64302263.9 · Necessity: For sale: Goods for tender participation · Description: Techno Medical Public Company Limited sells products to its subsidiaries at market prices. · As of yesteryear: 61698916.02 · Nature of transaction: Product Sales · Audit committee opinion: The Company has transactions with companies or individuals that may have conflicts of interest. These transactions are reasonable, comply with fair trade terms, are treated in the same manner as other unrelated individuals or businesses, and do not involve the transfer of benefits between companies. |
| 120000.0 · Necessity: Leasing of space for company parking expansion · Description: Techno Medical Public Company Limited rented land to expand its parking area on March 1, 2024. The lease will expire on March 1, 2027. · As of yesteryear: 120000.0 · Nature of transaction: Land Lease · Audit committee opinion: The Company has transactions with companies or individuals that may have conflicts of interest. These transactions are reasonable, comply with fair and generally accepted commercial terms applicable to unrelated parties, and do not involve the transfer of benefits between companies. |
| 113806.53 · Necessity: The Company's Policy on Acquisition of Goods at Market Price · Description: The Company's Policy on Acquisition of Goods at Market Price · As of yesteryear: 158915.89 · Nature of transaction: Product Purchase · Audit committee opinion: The company has transactions with companies or individuals that may have conflicts of interest. The list is reasonable, complies with fair trade terms and is treated the same as other unrelated individuals or businesses, and there is no transfer of benefits between companies. · 189797.58 · Necessity: Director purchased goods and services from The Parents Company Limited at market price. · Description: Director purchased goods and services from The Parents Company Limited at market price. · As of yesteryear: 206182.24 · Nature of transaction: Product Purchase · Audit committee opinion: The Company has transactions with companies or individuals that may have conflicts of interest. These transactions are reasonable, comply with fair and generally accepted commercial terms applied to unrelated parties, and do not involve the transfer of benefits between companies. |
| 112350.0 · Necessity: For leasing space to open a Nursing Care school · Description: Techno Medical Public Company Limited provided a lease for the 2nd floor of the Chanlongbutra building. The contract started on March 1, 2023, and ended on March 28, 2026, for a period of 3 years. · As of yesteryear: 105000.0 · Nature of transaction: Space rental · Audit committee opinion: The Company has a list of related parties with which it may have potential conflicts of interest. This list is reasonable, complies with fair trade practices, is treated the same as other unrelated individuals or entities, and does not involve the transfer of benefits between companies. · 1915.89 · Necessity: For use as a teaching tools. · Description: Techno Medical Public Company Limited sold disposable products to The Parents Training Center Company Limited. · As of yesteryear: 4285.98 · Nature of transaction: Product Sales · Audit committee opinion: The Company has transactions with companies or individuals that may have conflicts of interest. These transactions are reasonable, comply with fair trade terms, are treated in the same manner as other unrelated individuals or businesses, and do not involve the transfer of benefits between companies. |
| 720000.0 · Necessity: For the use of general business · Description: Techno Medical Public Company Limited purchased one electric vehicle for employee to use for general business purpose at market price. · Nature of transaction: Vehicle Procurement · Audit committee opinion: The Company has transactions with companies or individuals that may have conflicts of interest. These transactions are reasonable, comply with fair trade terms, are treated in the same manner as other unrelated individuals or businesses, and do not involve the transfer of benefits between companies. |
Policy & Future Trends
Introduction
At the Board of Directors' Meeting No. 1/2016 (the first meeting after the transformation into a public limited company) held on March 31, 2016, the Board of Directors approved the principles for measures and procedures for approving related party transactions.
The Board of Directors' Meeting No. 2/2021 reviewed the related party transaction policy as the Company had established subsidiaries.
Policy, Measures & Approval Process
1. Transactions with normal commercial terms
In cases where there are transactions between the Company or its subsidiaries with related persons, persons who may have a conflict of interest, persons having a vested interest, or persons who may have a conflict of interest in the future, which are commercial transactions of the same nature as a prudent person would enter into with an unrelated party under similar circumstances, with bargaining power free from the influence of being a director, executive, or related person, and with normal commercial terms or market prices, under reasonable, verifiable conditions that do not result in the transfer of benefits, the Company's management may proceed as usual under the principles approved by the Board of Directors and prepare a summary report to the Audit Committee every quarter.
2. Other related party transactions other than 1.
In cases where the related party transaction is not on normal commercial terms, the Company or its subsidiaries shall obtain an opinion from the Audit Committee regarding the necessity and appropriateness of such transaction. In the event that the Audit Committee does not have the expertise to consider the potential related party transaction, the Company or its subsidiaries shall consider having an independent appraiser, an independent specialist, or an auditor provide an opinion on such related party transaction to the Audit Committee for its consideration and opinion to the Board of Directors or shareholders, as the case may be, to approve such transaction prior to entering into the transaction. The Company shall disclose related party transactions in the Annual Information Form (Form 56-1) in accordance with the criteria and the law governing securities and exchange. The approval of such related party transactions must be in accordance with the Securities and Exchange Act and the regulations, announcements, orders, or requirements of the Stock Exchange of Thailand, whereby persons who may have a conflict of interest or have a vested interest in the related party transaction shall not be entitled to vote on such related party transaction. Policy or trend of related party transactions in the future
Future Trends in Related Party Transactions
In the future, if the Company or its subsidiaries need to enter into transactions with persons who may have a conflict of interest with the Company, the Company or its subsidiaries will set forth various conditions to be in line with the nature of normal business operations and at market prices which can be referenced and compared with the conditions or prices that occur with the same type of business that the Company conducts with outside parties. In this regard, the Company or its subsidiaries will have the Audit Committee provide an opinion on the price, remuneration rate, as well as the necessity and appropriateness of such related party transactions. In the event that the Audit Committee does not have expertise in considering related party transactions that may occur, the Company or its subsidiaries will consider having an independent appraiser, an independent expert, or the Company's auditor provide an opinion on such related party transactions for the Audit Committee to use in making its decision and providing an opinion to the Board of Directors or shareholders, as the case may be.
Related party transactions that may occur in the future, the Board of Directors must comply with the regulations prescribed by the Office of the Securities and Exchange Commission and the Stock Exchange of Thailand, and the Board of Directors shall not approve any transactions in which they or persons who may have a conflict of interest in any other manner with the Company, and must disclose such transactions to the Board of Directors for consideration, which the Company must comply with the Securities and Exchange Act and the rules, announcements, orders, or regulations of the Stock Exchange of Thailand, including compliance with the regulations regarding the disclosure of connected transactions and the acquisition or disposal of assets of the Company and in accordance with accounting standards prescribed by the Association of Certified Accountants. In addition, the Company will not engage in related party transactions with related companies that are not in the ordinary course of business of the Company.
Measures to Protect Investors
In order to protect investors, in the future, if there are any related party transactions of the Company or its subsidiaries with persons who may have a conflict of interest, have an interest, or may have a conflict of interest in the future, the Company will arrange for the presentation of such transactions through the Audit Committee meeting and the Board of Directors meeting with the Audit Committee in attendance (except for related party transactions that have a commercial agreement with general trading conditions, which the Board of Directors has approved in principle for the management to proceed). At the Board of Directors' Meeting No. 1/2016 (the first meeting after the conversion into a public limited company) on March 31, 2016, in order to ensure that related party transactions are fair and have an appropriate pricing policy, the Board of Directors must perform its duties in accordance with the Securities and Exchange Act and the rules, announcements, and regulations of the Stock Exchange of Thailand, including compliance with the regulations on the disclosure of connected transactions and the acquisition or disposal of material assets of listed companies. In addition, the Company also discloses related party transactions in the notes to the financial statements that have been audited or reviewed by the Company's auditors.

